Neurol. praxi. 2017;18(5):342-345 | DOI: 10.36290/neu.2017.013

Case reports of sporadic variants of Creutzfeldt-Jakob disease

MUDr. Tereza Lukoszová
Neurologické oddělení, Nemocnice Havlíčkův Brod

Prion diseases are the group of rare neurodegenerative diseases affecting both humans and animals, characterized by a longincubation period, rapidly progressing symptoms and infaust prognosis without the possibility of influencing the course of diseaseby therapy. The basic pathophysiological process is accumulation of "infectious" protein – prion in the brain tissue with itsirreversible spongiform damage. The most common human prion disease is Creutzfeldt-Jakob disease. It should be considered indifferential diagnostic process especially in cases of rapidly progressive dementia in combination with other neurological symptoms.The aim of this article is to really point out the issue of prion diseases and to briefly describe it in following case-reports ofsporadic Creutzfeldt-Jakob disease which was diagnosed at our department in years 2015 and 2016.

Keywords: prion diseases, prion, sporadic Creutzfeldt-Jakob disease, dementia

Received: March 6, 2017; Accepted: March 31, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lukoszová T. Case reports of sporadic variants of Creutzfeldt-Jakob disease. Neurol. praxi. 2017;18(5):342-345. doi: 10.36290/neu.2017.013.
Download citation

References

  1. Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89(4): 1105-1152. Go to original source... Go to PubMed...
  2. Aguzzi A, Falsig J. Prion propagation, toxicity and degradacion. Nat Neurosci 2012; 15(7): 936-939. Go to original source... Go to PubMed...
  3. Brownell B, Oppenheimer DR. An ataxic form of subacute presenile polioencephalopathy (Creutzfeldt-Jakob disease). J Neurol Neurosurg Psychiatry 1965; 28: 350-361. Go to original source... Go to PubMed...
  4. Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, Capellari S, Pastore M, Rahbar MH, Chen SG, Gambetti P. Sensitivity of 14-3-3 protein test varies in subtypes of Sporady Creutzfeldt-Jakob disease. Neurology 2004; 63(3): 436-442. Go to original source... Go to PubMed...
  5. Dvořáková E, Holada K. Konformačně specifické protilátky a diagnostika prionových chorob. Cesk Slov Neurol N 2012; 75/108(3): 283-290.
  6. Franková V, Krausová M. Lidské prionové nemoci. Psychiat. Praxi 2008; 9(3): 116-119.
  7. Franková V, Serbinová I, Matěj R, Koukolík F, Sikora J, Belšan T. Creutzfeldtova-Jakobova nemoc, kazuistika familiární formy onemocnění. Psychiat. Praxi 2004; 6: 317-321.
  8. Gdovinová Z. Creutzfeldtova-Jakobova choroba. Cesk Slov Neurol N 2013; 76/109(2): 138-154.
  9. Hönigová L, Neumann J. Heidenhainova varianta sporadické Creutzfeldtovy-Jakobovy nemoci. Neurol. praxi 2016; 17(3): 197-202. Go to original source...
  10. Kalp M, Gottschalk CHH. Mystery Case: Heidenhain variant of Creutzfeldt-Jakob diseace. Neurology 2014; 83: e187. Go to original source... Go to PubMed...
  11. Koukolík F, Matěj R. Lidské prionové nemoci. První zkušenosti a přehled literatury. Psychiatrie 2002; 6(3): 160-165.
  12. Koukolík F. Pitvy a bioptická vyšetření mozku při podezření na prionové choroby. Available from: http://www.patologie.info/standardy.php?zobrazit=11
  13. Kovács GG. MRI mozgu v diagnostike Creutzfeldtovej-Jakobovej choroby. Neurol. praxi 2007; 3: 149-151.
  14. Kratochvílová J. Doporučený pracovní postup pro ošetřování pacientů s podezřením na CJN, vCJN a režim dekontaminace a sterilizace. Available from: https://www.sneh.cz/_soubory/_clanky/4.pdf
  15. Kropp SF, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann CH, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S. The Heidenhain Variant of Creutzfeldt-Jakob disease. Arch Neurol 1999; 56(1): 55-61. Go to original source... Go to PubMed...
  16. Matěj R, Nováková J, Fiala J, Koukolík F, Rusina R. Vyšetřování proteinu 14-3-3 v mozkomíšním moku - klinicko-patologická korelace. Cesk Slov Neurol N 2008; 71/104(6): 695-699.
  17. Mareš J, Urbánek K, Herzig R. Nová varianta Creutzfeldtovy-Jakobovy nemoci. Neurol. praxi 2003; 1: 30-34.
  18. Mitrová E. Genetická forma humánních prionových chorob. Neurol. praxi 2006; 2: 76-79.
  19. Mitrová E. Prionové choroby a ich aktuálny epidemiologický význam. Neurol. praxi 2007; 3: 143-144.
  20. Pan KM, Baldwin M, Nquyen J, Gasser M, Serban A, Groth D, Mehlhorn I, Huang Z. Conversion of alpha-helices into beta-sheets features in the formativ of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90(23): 10962-10966. Go to original source... Go to PubMed...
  21. Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P, Gelpi E, Giaccone G, Hauw JJ, Höftberger R, Ironside JW, Jansen C, Kovács GG, Rozemuller A, Seilhean D, Tagliavini F, Giese A, Kretzschmar HA. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta neuropathol 2012; 124(4): 517-529. Go to original source... Go to PubMed...
  22. Poon MA, Stuckey S, Storey E. MRI evidence of cerebellar and hippocampal involvement in Creutzfeldt-Jakob disease. Neuroradiology 2001; 43: 746-749. Go to original source... Go to PubMed...
  23. Prusiner SB. The prion diseases. Brain Pathol 1998; 8(3): 499-513. Go to original source...
  24. Rohan Z, Matěj R, Rusina R. Překrývání neurodegenerativních demencí. Cesk Slov neurol N 2015; 78/111(6): 641-648. Go to original source...
  25. Rohan Z, Rusina R, Marešová M, Matěj R. Lidská prionová onemocnění v České republice. Epidemiol Mikrobiol Imunol 2015; 64(3): 115-120.
  26. Rohan Z, Parobková E, Johanidesová S, Koukolík F, Matěj R, Rusina R. Lidské prionové nemoci v České republice - 10 let zkušeností s diagnostikou. Cesk Slov Neurol N 2013; 76/109(3): 300-306.
  27. Rusina R, Matěj R. Prionová onemocnění. Neurol. praxi 2012; 13(2): 78-82.
  28. Safar J, Roller PP, Gajdusek DC, Gibbs CJ jr. Conformational transicions, dissociation and unfolding of scrapie amyloid (prion) protein. J Biol chem 1993; 268(27): 20276-20284. Go to original source...
  29. Shiga Y, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, Konno H, Doh-ura K, Mugikura S, Tamura H, Higano S, Takahashi S, Itoyama Y. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63: 443-449. Go to original source... Go to PubMed...
  30. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347(9006): 921-925. Go to original source... Go to PubMed...
  31. Young GS, Geschwind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP. Diffusion-weighted and fluid-attenuated inversion recovery paging in Creutzfeld-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005; 26: 1551-1562.
  32. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, Van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic kriteria for sporady Creutzfeldt-Jakob disease. Brain 2009; 132(Pt 10): 2659-2668. Go to original source... Go to PubMed...
  33. Case courtesy of A. Prof Frank Gaillard, Radiopaedia.org. From the case rID: 43677, https://radiopaedia.org/cases/43677
  34. Case courtesy of Dr Maxime St-Amant, Radiopaedia.org. From the case rID: 18712, https://radiopaedia.org/cases/18712




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.